Skip to content

Systematic Calculation of HyperOxygenation Transit Time

Systematic Calculation of HyperOxygenation Transit Time Mesure transcutanée de l'oxygène au Cours de l'Hyperoxie Transitoire

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04007146
Acronym
SCHOTT
Enrollment
1
Registered
2019-07-05
Start date
2020-03-01
Completion date
2021-09-01
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Output

Keywords

Cardiac Output, vascular medicine, Transcutaneous Oxymetry

Brief summary

Cardiac output (CO) is an essential physiological parameter of healthy person or illness. In clinical practices, all methods of measuring the CO(Fick method, thoracic impedance, esophageal echodoppler etc) contain limit. Each method are dangerous or hard to implement. CO is probably determining element of blood transit time and thus the availability of oxygen between the central organs (heart, lung) and the peripheral organs (leg, arms). Our hypothesis is transcutaneous oxymetry mesurement with oxygen inhalation, to cause a transient hyperoxia, can be used to determinate blood transit time between central organs and peripheral organs. This simple method will be non invasive technique.

Detailed description

At admission eligible patients are proposed to participate. Written consent is signed after complete oral and written explanation of the protocol is signed. The time of onset hyperoxia will be compare to usual CO method by cross correlation. The duration of participation for subject is equal to 1 hour.

Interventions

DIAGNOSTIC_TESTTranscutaneous oxymetry measurement

Transcutaneous oxymetry measurement with transient hyperoxia period (2 periods of 30seconds at 60% of oxygen)

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults over 18 * Cardiac output measurement considered at least 2 hours prior to the study * Affiliation to a French National healthcare system * Written informed consent must be obtained prior to protocol-specific

Exclusion criteria

* Acute or decompensated cardiac or respiratory failure * Allergy to medical adhesives * Patients under reinforced protection, pregnancy, deprived of liberty by judicial or administrative decision, hospitalized without consent or admitted to a health or social establishment for purposes other than research * Inability to understand the instructions or objectives of the study

Design outcomes

Primary

MeasureTime frameDescription
Estimation of transcutaneous oxymetry with transient hyperoxia24 monthsTransition time calcutation from oxygen to peripheral organs by transcutaneous oxymetry method.
Average of CO measured24 monthsAverage of CO by usual method (catheterisation or transoesophageal echocardiography) reported in medical record of patients

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026